{"transactions":[{"id":672831,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":1740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 9, 2018, the reporting person was granted stock options to purchase up to 5,220 shares of common stock. The options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020."}],"balance_after":3480,"derivative":{"exercise_price":30,"expiration_date":"2028-08-08","underlying":"Common Stock","underlying_shares":1740},"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":672830,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 18, 2017, the reporting person was granted stock options to purchase up to 4,205 shares of common stock. The options vest 6/42nds at the six-month anniversary of grant date and 1/42nd per month thereafter."}],"balance_after":2803,"derivative":{"exercise_price":30,"expiration_date":"2027-09-17","underlying":"Common Stock","underlying_shares":1402},"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":672829,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":1802,"price":113.05,"value":203716.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.84 to $113.11, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4."}],"balance_after":5373,"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":672828,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":646,"price":111.07,"value":71751.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.56 to $111.41, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":672827,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":694,"price":110.04,"value":76367.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.51 to $110.43, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4."}],"balance_after":7821,"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":672826,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":1740,"price":30,"value":52200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."}],"balance_after":8515,"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":672825,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T23:41:10.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":1402,"price":30,"value":42060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026."}],"balance_after":6775,"source":{"system":"sec-edgar","filing":"0001437749-26-029228","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029228/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-27"}},{"id":673601,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-27T22:27:56.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":1802,"price":113.05,"value":203716.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on 05/26/2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.84 to $113.11, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4."}],"balance_after":23751,"source":{"system":"sec-edgar","filing":"0001437749-26-029115","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029115/rdgdoc.xml","form_type":"4"}},{"id":673600,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-27T22:27:56.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":646,"price":110.07,"value":71105.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on 05/26/2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.56 to $111.41, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4."}],"balance_after":25523,"source":{"system":"sec-edgar","filing":"0001437749-26-029115","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029115/rdgdoc.xml","form_type":"4"}},{"id":673599,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-27T22:27:56.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":694,"price":110.04,"value":76367.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on 05/26/2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.51 to $110.43, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4."}],"balance_after":26169,"source":{"system":"sec-edgar","filing":"0001437749-26-029115","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774926029115/rdgdoc.xml","form_type":"4"}},{"id":977381,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-08T21:48:43.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":2924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026"}],"balance_after":2924,"derivative":{"exercise_price":75.94,"expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":2924},"source":{"system":"sec-edgar","filing":"0001437749-25-037168","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774925037168/rdgdoc.xml","form_type":"4"}},{"id":1216995,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-03-08T00:55:20.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":11365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025"}],"balance_after":11365,"derivative":{"exercise_price":31.7,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":11365},"source":{"system":"sec-edgar","filing":"0001437749-25-006725","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774925006725/rdgdoc.xml","form_type":"4"}},{"id":1691323,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-04T00:40:57.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-24-000488","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774924000488/rdgdoc.xml","form_type":"4"}},{"id":1691322,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-04T00:40:57.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":26863,"source":{"system":"sec-edgar","filing":"0001437749-24-000488","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774924000488/rdgdoc.xml","form_type":"4"}},{"id":1766772,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-10-03T23:31:05.000Z","date":"2023-09-30","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2533,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-23-027582","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923027582/rdgdoc.xml","form_type":"4"}},{"id":1766771,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-03T23:31:05.000Z","date":"2023-09-30","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":24330,"source":{"system":"sec-edgar","filing":"0001437749-23-027582","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923027582/rdgdoc.xml","form_type":"4"}},{"id":1839391,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-07-03T22:50:28.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":2534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":5066,"derivative":{"underlying":"Common Stock","underlying_shares":2534},"source":{"system":"sec-edgar","filing":"0001437749-23-019262","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923019262/rdgdoc.xml","form_type":"4"}},{"id":1839390,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-03T22:50:28.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":2534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":21797,"source":{"system":"sec-edgar","filing":"0001437749-23-019262","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923019262/rdgdoc.xml","form_type":"4"}},{"id":1927170,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-04T21:18:21.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":7600,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-23-009334","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923009334/rdgdoc.xml","form_type":"4"}},{"id":1927169,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-04T21:18:21.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":19263,"source":{"system":"sec-edgar","filing":"0001437749-23-009334","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923009334/rdgdoc.xml","form_type":"4"}},{"id":2032403,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-02-03T23:51:20.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":10133,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10133},"source":{"system":"sec-edgar","filing":"0001437749-23-002520","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923002520/rdgdoc.xml","form_type":"4"}},{"id":2032402,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-02-03T23:51:20.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":13930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":13930,"derivative":{"exercise_price":3.16,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":13930},"source":{"system":"sec-edgar","filing":"0001437749-23-002520","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923002520/rdgdoc.xml","form_type":"4"}},{"id":2072213,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-03T21:11:26.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001437749-23-000173","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923000173/rdgdoc.xml","form_type":"4"}},{"id":2072212,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-03T21:11:26.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":16730,"source":{"system":"sec-edgar","filing":"0001437749-23-000173","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000143774923000173/rdgdoc.xml","form_type":"4"}},{"id":2147011,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-10-03T23:38:42.000Z","date":"2022-09-30","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2859,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-013276","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422013276/section16.xml","form_type":"4"}},{"id":2147010,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-10-03T23:38:42.000Z","date":"2022-09-30","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":13871,"source":{"system":"sec-edgar","filing":"0001654954-22-013276","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422013276/section16.xml","form_type":"4"}},{"id":2216824,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-07-01T20:14:44.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":5718,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-009142","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422009142/section16.xml","form_type":"4"}},{"id":2216823,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-07-01T20:14:44.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":11012,"source":{"system":"sec-edgar","filing":"0001654954-22-009142","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422009142/section16.xml","form_type":"4"}},{"id":2310866,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-04-01T21:02:42.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":8577,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-004479","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422004479/section16.xml","form_type":"4"}},{"id":2310865,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-04-01T21:02:42.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":8153,"source":{"system":"sec-edgar","filing":"0001654954-22-004479","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422004479/section16.xml","form_type":"4"}},{"id":2411459,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-02-05T00:33:06.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":11436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."}],"balance_after":11436,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11436},"source":{"system":"sec-edgar","filing":"0001654954-22-001169","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422001169/section16.xml","form_type":"4"}},{"id":2411458,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2022-02-05T00:33:06.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":15128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."}],"balance_after":15128,"derivative":{"exercise_price":2.8,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":15128},"source":{"system":"sec-edgar","filing":"0001654954-22-001169","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422001169/section16.xml","form_type":"4"}},{"id":2447880,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-01-04T18:45:29.000Z","date":"2021-12-31","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-22-000121","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422000121/section16.xml","form_type":"4"}},{"id":2447879,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-01-04T18:45:29.000Z","date":"2021-12-31","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":5294,"source":{"system":"sec-edgar","filing":"0001654954-22-000121","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495422000121/section16.xml","form_type":"4"}},{"id":2554026,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T23:27:52.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":751,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-21-010717","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421010717/section16.xml","form_type":"4"}},{"id":2554025,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-10-01T23:27:52.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":4543,"source":{"system":"sec-edgar","filing":"0001654954-21-010717","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421010717/section16.xml","form_type":"4"}},{"id":2643866,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-07-02T21:18:14.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":1502,"derivative":{"underlying":"Common Stock","underlying_shares":752},"source":{"system":"sec-edgar","filing":"0001654954-21-007604","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421007604/section16.xml","form_type":"4"}},{"id":2643865,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-07-02T21:18:14.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":3792,"source":{"system":"sec-edgar","filing":"0001654954-21-007604","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421007604/section16.xml","form_type":"4"}},{"id":2763487,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-04-01T23:41:05.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2254,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-21-003789","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421003789/section16.xml","form_type":"4"}},{"id":2763486,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-04-01T23:41:05.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":3040,"source":{"system":"sec-edgar","filing":"0001654954-21-003789","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421003789/section16.xml","form_type":"4"}},{"id":2891916,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-28T23:57:55.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."}],"balance_after":3005,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001654954-21-000921","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421000921/section16.xml","form_type":"4"}},{"id":2891915,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2021-01-28T23:57:55.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":4443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."}],"balance_after":4443,"derivative":{"exercise_price":6.81,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":4443},"source":{"system":"sec-edgar","filing":"0001654954-21-000921","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421000921/section16.xml","form_type":"4"}},{"id":2919391,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T22:29:53.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-21-000148","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421000148/section16.xml","form_type":"4"}},{"id":2919390,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T22:29:53.000Z","date":"2020-09-30","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":322,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-21-000148","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421000148/section16.xml","form_type":"4"}},{"id":2919389,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-01-05T22:29:53.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":2289,"source":{"system":"sec-edgar","filing":"0001654954-21-000148","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421000148/section16.xml","form_type":"4"}},{"id":2919388,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-01-05T22:29:53.000Z","date":"2020-09-30","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":1967,"source":{"system":"sec-edgar","filing":"0001654954-21-000148","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495421000148/section16.xml","form_type":"4"}},{"id":3091052,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2020-07-02T20:38:21.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":644,"derivative":{"underlying":"Common Stock","underlying_shares":323},"source":{"system":"sec-edgar","filing":"0001654954-20-007304","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495420007304/section16.xml","form_type":"4"}},{"id":3091051,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2020-07-02T20:38:21.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":1645,"source":{"system":"sec-edgar","filing":"0001654954-20-007304","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495420007304/section16.xml","form_type":"4"}},{"id":3188810,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2020-04-01T18:36:17.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":967,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-20-003675","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495420003675/section16.xml","form_type":"4"}},{"id":3188809,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2020-04-01T18:36:17.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":1322,"source":{"system":"sec-edgar","filing":"0001654954-20-003675","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495420003675/section16.xml","form_type":"4"}},{"id":3258992,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2020-02-21T01:57:06.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":5646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest 25% on March 31, 2020, 25% on June 30, 2020, 25% on September 30, 2020, and 25% on December 31, 2020."}],"balance_after":5646,"derivative":{"exercise_price":14.35,"expiration_date":"2030-01-31","underlying":"Common Stock","underlying_shares":5646},"source":{"system":"sec-edgar","filing":"0001654954-20-001793","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495420001793/section16.xml","form_type":"4"}},{"id":3258991,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2020-02-21T01:57:06.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":1289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021."}],"balance_after":1289,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1289},"source":{"system":"sec-edgar","filing":"0001654954-20-001793","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495420001793/section16.xml","form_type":"4"}},{"id":3806440,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock options","published_at":"2018-09-27T22:49:09.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020."}],"balance_after":26100,"derivative":{"exercise_price":6,"exercise_date":"2019-01-01","expiration_date":"2028-08-08","underlying":"Common stock","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001654954-18-010578","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362489/000165495418010578/section16.xml","form_type":"4"}},{"id":4574185,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-26T16:38:57.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":5.49,"expiration_date":"2022-09-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-16-083648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083648/doc1.xml","form_type":"4"}},{"id":4574184,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-26T16:38:57.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":5.13,"expiration_date":"2021-09-22","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001140361-16-083648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083648/doc1.xml","form_type":"4"}},{"id":4574183,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-26T16:38:57.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.54,"expiration_date":"2020-11-22","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001140361-16-083648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083648/doc1.xml","form_type":"4"}},{"id":4574182,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-26T16:38:57.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":2.97,"expiration_date":"2020-10-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-16-083648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083648/doc1.xml","form_type":"4"}},{"id":4574181,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-26T16:38:57.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":8330,"price":9,"value":74970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding restricted stock unit was accelerated in full and cancelled in exchange for the right to receive $9.00 per share in cash, without interest and less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-16-083648","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083648/doc1.xml","form_type":"4"}},{"id":4574180,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":18675,"kind":"person","name":"Anderson Raymond","position":1,"cik":"0001362489","reported_name":"Anderson Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-26T16:38:57.000Z","date":"2016-10-24","kind":"other","acquired":false,"shares":6695,"price":9,"value":60255.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares tendered in connection with an offer to purchase all of the issued and outstanding shares of common stock of Raptor Pharmaceutical Corp. (\"Raptor\"), par value $0.001 per share, for an amount of $9.00 per share in cash, without interest and less any applicable withholding taxes, commenced pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 12, 2016, by and among Raptor, Horizon Pharma plc, a public limited company organized under the laws of Ireland (\"Parent\") and Misneach Corporation, a Delaware corporation and an indirect wholly owned subsidiary of Parent."}],"balance_after":8330,"source":{"system":"sec-edgar","filing":"0001140361-16-083648","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083648/doc1.xml","form_type":"4"}}]}